AR032695A1 - Composicion farmaceutica - Google Patents

Composicion farmaceutica

Info

Publication number
AR032695A1
AR032695A1 ARP020100516A ARP020100516A AR032695A1 AR 032695 A1 AR032695 A1 AR 032695A1 AR P020100516 A ARP020100516 A AR P020100516A AR P020100516 A ARP020100516 A AR P020100516A AR 032695 A1 AR032695 A1 AR 032695A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
thieno
benzylamino
pyrimidin
benzo
Prior art date
Application number
ARP020100516A
Other languages
English (en)
Inventor
Schreder Sven Dr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR032695A1 publication Critical patent/AR032695A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Composicion farmacéutica de elevada biodisponibilidad para la administracion oral de ácido 4-[4-(3-cloro-4-metoxi-bencilamino)-benzo [4,5] tieno [2,3-d]pirimidin-2-il]-ciclohexancarboxílico y/o ácido 4-[4-(3-cloro-4hidroxi-bencilamino)-benzo[4,5]tieno[2,3]-dpirimidin-2-il]-ciclohexancarboxílico o de sus sales aptas para uso farmacéutico, con un procedimiento para preparar la composicion farmacéutica y con su uso.
ARP020100516A 2001-02-16 2002-02-15 Composicion farmaceutica AR032695A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10107261A DE10107261B4 (de) 2001-02-16 2001-02-16 Pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
AR032695A1 true AR032695A1 (es) 2003-11-19

Family

ID=7674278

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100516A AR032695A1 (es) 2001-02-16 2002-02-15 Composicion farmaceutica

Country Status (21)

Country Link
US (1) US20040082600A1 (es)
EP (1) EP1385521A2 (es)
JP (1) JP2004519489A (es)
KR (1) KR20030074822A (es)
CN (1) CN1649592A (es)
AR (1) AR032695A1 (es)
BR (1) BR0207271A (es)
CA (1) CA2438401A1 (es)
CZ (1) CZ20032423A3 (es)
DE (1) DE10107261B4 (es)
EC (1) ECSP034769A (es)
EE (1) EE200300378A (es)
HU (1) HUP0303141A3 (es)
IL (1) IL157411A0 (es)
MX (1) MXPA03007318A (es)
PE (1) PE20021039A1 (es)
PL (1) PL364467A1 (es)
RU (1) RU2003127393A (es)
SK (1) SK11352003A3 (es)
WO (1) WO2002072100A2 (es)
ZA (1) ZA200307216B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101065115A (zh) * 2004-11-24 2007-10-31 默克公司 取代酰胺的液体和半固体口服药物制剂
WO2013109354A2 (en) * 2011-12-07 2013-07-25 Texas Southern University Etravirine formulations and uses thereof
JP6943384B2 (ja) * 2017-03-01 2021-09-29 ヱスビー食品株式会社 食品の食感劣化防止用ソフトカプセル、並びに、該食感劣化防止用ソフトカプセル及び食用油を含有する食品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0517412A1 (en) * 1991-06-03 1992-12-09 MERCK SHARP & DOHME LTD. Pharmaceutical formulations of a benzodiazepine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
DE19928146A1 (de) * 1999-06-19 2000-12-21 Merck Patent Gmbh Thienopyrimidine
EP1255565A1 (de) * 2000-01-13 2002-11-13 MERCK PATENT GmbH Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung

Also Published As

Publication number Publication date
PE20021039A1 (es) 2002-11-14
US20040082600A1 (en) 2004-04-29
HUP0303141A2 (hu) 2003-12-29
EE200300378A (et) 2003-10-15
WO2002072100A2 (en) 2002-09-19
MXPA03007318A (es) 2003-12-04
SK11352003A3 (sk) 2003-12-02
DE10107261A1 (de) 2002-09-12
CA2438401A1 (en) 2002-09-19
DE10107261B4 (de) 2005-03-10
JP2004519489A (ja) 2004-07-02
EP1385521A2 (en) 2004-02-04
WO2002072100A3 (en) 2003-11-06
CN1649592A (zh) 2005-08-03
BR0207271A (pt) 2004-03-23
ECSP034769A (es) 2003-12-24
HUP0303141A3 (en) 2006-05-29
ZA200307216B (en) 2005-01-13
IL157411A0 (en) 2004-03-28
PL364467A1 (en) 2004-12-13
RU2003127393A (ru) 2005-01-20
KR20030074822A (ko) 2003-09-19
CZ20032423A3 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
DE60209145D1 (de) Pharmazeutische formulierungen mit platinderivaten
AR029471A1 (es) Forma cristalina de la sal de disodio del acido n- [4- [2-(2-amino-4,7-dihidro-4-oxo-3h-pirrolo[2,3-d]pirimidin-5-il)etil]benzoil] -l-glutrmico-forma cristalina heptahidrato-; procedimiento de uso de dicha forma en la fabricacion de medicamentos para el tratamiento del cancer; formulaciones farmaceu
NO20063231L (no) Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
NO20023527D0 (no) Pyrido(2,3-d)pyrimidin-2,7-diamin kinaseinhibitorer
AR055099A1 (es) Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
NO20032909D0 (no) Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
ATE267601T1 (de) Pharmazeutische zusammensetzung enthaltend pemetrexed zusammen mit monothioglycerol, l- cystein oder thioglykolsäure
ATE415949T1 (de) Pharmazeutische formulierung mit levothyroxin- natrium
BRPI0510820A (pt) composição farmacêutica, forma unitária de dosagem e seus usos
AR032695A1 (es) Composicion farmaceutica
AR027624A1 (es) Forma de dosificacion oral para la administracion de la combinacion de tegafur, uracilo y acido folinico, y oxaliplatino y metodo de uso de los mismos
PA8519501A1 (es) Farnesil transferasa inhibidora del enantiomero de quinolina 1,2-anillado
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
AU2003257982A1 (en) Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
HN2000000057A (es) Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano.
AR029091A1 (es) Uso de compuestos de 1-amino-5-fenilpentano-3-ol y/o 1-amino-6-fenilhexano-3-ol para la preparacion de un medicamento con efecto antagonista de n-metil-d-aspartato-(nmda)
DK1140810T3 (da) Benzensulfonamidderivater samt deres anvendelse
ITRM20020119A0 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
ES2181506T3 (es) Vancoresmicina, un procedimiento para su produccion y su uso como producto farmaceutico.
BR0208814A (pt) Uso de derivados de ariletenossulfonamida
DE60312642D1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung

Legal Events

Date Code Title Description
FA Abandonment or withdrawal